Molecule Details
| InChIKey | PYDRNERUXUSFJW-HHHXNRCGSA-N |
|---|---|
| Compound Name | 3-N-cyclopropyl-5-[3-[5-[(3,5-dichloro-4-pyridinyl)carbamoylamino]-1-ethyl-6-oxopyridazin-3-yl]phenyl]-1-N-[2-[(2R)-1-methylpyrrolidin-2-yl]ethyl]benzene-1,3-dicarboxamide |
| Canonical SMILES | CCn1nc(-c2cccc(-c3cc(C(=O)NCC[C@H]4CCCN4C)cc(C(=O)NC4CC4)c3)c2)cc(NC(=O)Nc2c(Cl)cncc2Cl)c1=O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.85 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile